Stock code: 688271 Stock abbreviation: United Imaging Medical Announcement No.: 2025-002

Shanghai United Imaging Medical Technology Co., Ltd

Shareholder inquiry transfer plan

Shanghai Zhongke State Street Investment Partnership (Limited Partnership) (hereinafter referred to as "Zhongke State Street") and Shanghai Beiyuan Investment Partnership (Limited Partnership) (hereinafter referred to as "Beiyuan Investment") (hereinafter collectively referred to as the "Transferor") guarantee that the information provided to Shanghai United Imaging Medical Technology Co., Ltd. (hereinafter referred to as the "Company" or "United Imaging Healthcare") does not contain any false records, misleading statements or material omissions, and assumes legal responsibility for its authenticity, accuracy and completeness in accordance with the law.

The company and all members of the board of directors ensure that the content of the announcement is consistent with the information provided by the information disclosure obligor.

Important Content Notes:

Shares that intend to participate in the pre-IPO shareholder inquiry transfer (hereinafter referred to as the "inquiry transfer") of United Imaging Medical

the east is Zhongke Daofu and Beiyuan Investment;

The total number of shares to be transferred by the transferor is 29,086,400 shares, accounting for the total share capital of United Imaging Healthcare

3.53%；

The inquiry transfer is a non-public transfer and is not carried out through centralized bidding transactions or block transactions.

It is not a reduction through the secondary market. The transferee transfers the transferred shares through an inquiry, after the transfer

Non-transferable for 6 months;

The transferee of this inquiry transfer is an institutional investment with corresponding pricing power and risk tolerance

He who.

Over the years, Zhongke State Street and Beiyuan Investment have actively contributed to the development of cutting-edge technology in China's medical industry

The funds after the reduction will continue to be used for industry investment and inject strength into the development of China's medical industry.

1. Shareholders to participate in the transfer

(1) The name of the transferor, the number of shares held, and the proportion of shares

The transferor entrusts China International Capital Corporation Limited (hereinafter referred to as "CICC") to organize the implementation

This inquiry is transferred. As of March 14, 2025, the number of pre-IPO shares held by the transferor, accounting for the total shares

The proportions are as follows:

Serial No. Name of Shareholder Number of Shares Held (Shares) Shareholding Ratio

1 Zhongke Daofu 41,463,858 5.03%

2 North Yuan Investment 28,830,361 3.50%

(2) Whether the transferor is the controlling shareholder, actual controller, or shareholder of more than 5% of the company

Directors, supervisors and senior management

The transferor of this inquiry, Zhongke State Street and Beiyuan Investment, are not the controlling shareholders, actual controllers, directors, supervisors and senior management of the company.

State Street and Beiyuan Investment are both private equity investment funds in which Shanghai Daofu Yuantong Equity Investment Management Co., Ltd. serves as the private equity fund manager, and they are in a concerted action relationship, and Zhongke State Street and Beiyuan Investment hold more than 5% of the company's shares in total, and are shareholders of more than 5% of the company's shares.

(3) A statement by the transferor that the ownership of the shares to be transferred is clear and that there are no restrictions or prohibitions on the transfer

The transferor declares that the shares held by the transferor have been released from the restriction on sale, and the ownership is clear.

The transferor is not allowed to reduce its shareholdings as stipulated in the Interim Measures for the Administration of Shareholding Reduction by Shareholders of Listed Companies and the Self-Regulatory Guidelines for Listed Companies No. 15 of the Shanghai Stock Exchange - Reduction of Shareholdings by Shareholders, Directors, Supervisors and Senior Managers.

The transferor has not violated the provisions on the reduction of shareholdings or the commitments made by the transferor.

(4) The transferor's commitment to have sufficient pre-IPO shares available for transfer and to strictly fulfill the relevant obligations

The transferor undertakes to have sufficient pre-IPO shares available for transfer and to strictly fulfill the relevant obligations.

Second, the main content of the inquiry transfer plan

(1) The basic situation of the inquiry transfer

The number of shares transferred in this inquiry is 29,086,400 shares, accounting for 3.53% of the total share capital, transferred

The reasons are all their own financial needs.

Shareholders to be transferred The number of shares to be transferred Accounts for the total share capital and the shares held

Name (shares) Proportion Proportion (as of 2025 Reason for transfer.)

March 14, 2019)

Zhongke State Street 17,157,000 2.08% 41.38% Own capital needs

Beiyuan Investment 11,929,400 1.45% 41.38% Own capital needs

(2) The basis for determining the lower limit of the transfer price and the principles and methods for determining the transfer price

In accordance with the requirements of the Self-Regulatory Guidelines for Listed Companies on the Science and Technology Innovation Board of the Shanghai Stock Exchange No. 4 - Inquiry Transfer and Placement, the lower price limit of this inquiry transfer shall not be lower than the date of sending the invitation to subscribe (i.e., 2025).

March 14, inclusive) 70% of the average stock trading price for the previous 20 trading days. The transferor and CICC combined

Taking into account the shareholders' own capital needs and other factors, the lower limit of the price of this inquiry transfer is determined through negotiation. After the quotation of this inquiry subscription is completed, CICC will conduct cumulative statistics on the valid subscriptions, and determine the transfer price in accordance with the principles of price priority, subscription quantity priority, and time priority of receipt of the Subscription Quotation.

Here's how:

1. If the number of valid subscribed shares transferred by this inquiry is equal to or exceeds the upper limit of the number of shares transferred in this inquiry, the determination principle of the inquiry transfer price, subscription object and the number of allotted shares is as follows (priority according to the order of serial number):

(1) Priority of subscription price: Sort and accumulate according to the declared price from high to low;

(2) Priority of subscription quantity: if the declared price is the same, it will be sorted and accumulated according to the subscription quantity from large to small;

(3) Priority in the time of receipt of the Subscription Quotation: If the declared price and subscription quantity are the same, the Subscription Quotation will be sent to the designated email address or personal delivery time in accordance with the Subscription Quotation (if the Subscription Quotation is delivered by both email and special person, the valid Subscription Quotation received by CICC for the first time within the specified time shall prevail) will be sorted and accumulated from first to first, and the effective subscription with the earliest time will be prioritized.

When the total number of shares validly subscribed is equal to or exceeds 29,086,400 shares for the first time, the lowest subscription price of the cumulative valid subscription is the transfer price of this inquiry.

2. If the total number of valid subscribed shares of the inquiry object is less than 29,086,400 shares, the lowest quotation in all valid subscriptions will be determined as the transfer price of this inquiry.

(3) The securities company entrusted to organize the implementation of this inquiry transfer is CICC

Contact Department: Capital Markets Department, CICC

Project mailbox: ECM_LYYL@cicc.com.cn

Contact and consultation telephone: 010-89620585

(4) Conditions for investors participating in the transfer

The transferees of this inquiry transfer are institutional investors with corresponding pricing power and risk tolerance, including:

1. Institutional investors who meet the conditions for offline investors in the initial public offering of securities in the Implementation Rules of the Shanghai Stock Exchange for Initial Public Offering of Securities or other institutional investors (including the products under their management) stipulated by the Shanghai Stock Exchange, i.e., professional institutional investors such as securities companies, fund management companies, futures companies, trust companies, insurance companies, finance companies, qualified foreign investors and private equity fund managers;

2. In addition to the professional institutional investors specified in the preceding paragraph, other private fund managers that have completed registration with the Asset Management Association of China (and the products under their management that intend to participate in the transfer of this inquiry have been filed with the Asset Management Association of China).

3. Relevant risk warnings

(1) There is a risk that the implementation of the inquiry transfer plan will be affected by the judicial freezing and deduction of the shares due to the sudden situation of the transferor after the disclosure of the "Inquiry and Transfer Plan for Shareholders of Shanghai United Imaging Medical Technology Co., Ltd." and the "Verification Opinions of China International Capital Corporation on the Relevant Qualifications of Shareholders of Shanghai United Imaging Medical Technology Co., Ltd. to Inquire and Transfer Shares to Specific Institutional Investors".

(2) There may be a risk that the implementation of the inquiry transfer plan will be suspended due to major changes in the market environment.

IV. Annexes

China International Capital Corporation Limited's Verification Opinions on the Qualifications of Shareholders of Shanghai United Imaging Medical Technology Co., Ltd. to Inquire about the Transfer of Shares to Specific Institutional Investors.

The announcement is hereby made.

Board of Directors of Shanghai United Imaging Medical Technology Co., Ltd

March 15, 2025